This study indicates that JNDX noticeably improves the dysbiosis of gut microbiota and affects BAs (CA and UDCA) metabolism in T2DM rats, both of which have been shown in modern research to activate the “BAs–FXR/FGF15”pathway, thereby improving T2DM. The gene discussed is NR1H4; the disease is type 2 diabetes mellitus.